US-based Mevion Medical Systems is set to introduce new Hyperscan system which claimed to delivering pencil beam scanning at higher speed.
The Hyperscan technology has been built based on the MEVION S250 proton therapy platform, which has been operating since December 2013.
The Hyperscan system offers rapid volumetric and layer rescanning, a streamlined image-based clinical workflow, sub-millimeter position tracking and beam gating connectivity.
By using a sharp beam of radiation, the patented technology of Hyperscan allows radiation to be precisely delivered, with the tumor being volumetrically scanned in few seconds, said Mevion.
Current pencil beam delivery systems are sensitive to motion, while Hyperscan’s fast beam delivery is less sensitive to patient and tumor motions, which allows in better treatment.
Mevion Medical Systems president and CEO Joseph Jachinowski said the Hyperscan enables treatment with fine precision at tremendous speed and with uncompromised beam quality.
"This new technological advance will help providers deliver the best possible cancer care to the patients who need it most," Jachinowski added.
Mevion will debut the Hyperscan system at the the 56th annual meeting of the American Society for Radiation Oncology, which will be held at San Francisco, US, between 14-16 September.
The US Food and Drug Administration has not yet approved Hyperscan, according to the company.
Image: Hyperscan debuts at the 56th annual meeting of the American Society for Radiation Oncology in San Francisco. Photo: courtesy of Business Wire.